In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions
Healthy
Interventions
OTHER

Associated product 1 : RV2666C

Applied twice a day minimum during 7 days (from Day 1 to Day 7)

OTHER

Associated product 2 MORNING : RV5000A

"Applied in the mornings from Day 8 to Day 95 or Day 176\*~\* for subjects post injections"

OTHER

Test product : RV4983A

"Applied once a day, at the evening. Avoid contact with eyes. If sensations of discomfort appear, allow more time between applications.~* From Day 8 to Day 95 (87 days) for post LASER and post peeling subjects~* From Day 8 to Day 176 (169 days) for post-injections subjects"

OTHER

Associated product 2 EVENING: RV5000A

"Applied in the evenings from Day 8 to Day 95 or Day 176\*~\* for subjects post injections"

Trial Locations (1)

80288

Dermscan Poland, Gdansk

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT06942403 - In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization | Biotech Hunter | Biotech Hunter